Skip to main content

MoneyWorks4Me

Clinitech Laboratory informs about disclosure

10 Mar 2026 Evaluate
Clinitech Laboratory has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jagdish Umakant Nayak.

The above information is a part of company’s filings submitted to BSE.
Peers